BioHealth News

Volition: Celebrating women in science: empowering the future

Volition: Celebrating women in science: empowering the future

Read More
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs

MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs

Read More
Maryland Economic Headwinds? Time to Invest in Economies of the Future

Maryland Economic Headwinds? Time to Invest in Economies of the Future

Read More
New GW Study Highlights Importance of Measuring Well-Being in Mental Health Research

New GW Study Highlights Importance of Measuring Well-Being in Mental Health Research

Read More
Previous BHCR Crab Trap Winner LifeSprout Completes CE Mark Submission for Lumina™, a Next-Generation Aesthetics Dermal Filler

Previous BHCR Crab Trap Winner LifeSprout Completes CE Mark Submission for Lumina™, a Next-Generation Aesthetics Dermal Filler

Read More
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

Read More
Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk

Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk

Read More
APT – SCOPE Summit 2025: Emmes’ Peter Ronco on Small Biopharma & Clinical Trial Partnerships

APT – SCOPE Summit 2025: Emmes’ Peter Ronco on Small Biopharma & Clinical Trial Partnerships

Read More
Children’s National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health

Children’s National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health

Read More
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Read More
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

Read More
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Read More
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

Read More
MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

Read More
Georgetown Entrepreneurs Win $150,000 in Prizes During Annual ‘Bark Tank’ Pitch Competition

Georgetown Entrepreneurs Win $150,000 in Prizes During Annual ‘Bark Tank’ Pitch Competition

Read More
View All Posts